Pacira BioSciences, Inc.
PCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5 | -$5 | $5 | $16 |
| Dep. & Amort. | $21 | $27 | $21 | $21 |
| Deferred Tax | $8 | $1 | $1 | $4 |
| Stock-Based Comp. | $14 | $15 | $15 | $12 |
| Change in WC | -$16 | -$38 | $1 | -$24 |
| Other Non-Cash | $28 | $12 | -$8 | $4 |
| Operating Cash Flow | $61 | $12 | $35 | $33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$3 | -$9 | -$2 |
| Net Acquisitions | $0 | $0 | -$17 | $0 |
| Inv. Purchases | -$39 | -$6 | -$70 | -$45 |
| Inv. Sales/Matur. | $86 | $71 | $69 | $47 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $44 | $62 | -$26 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$205 | -$4 | -$3 | -$3 |
| Stock Issued | $0 | $2 | $0 | $0 |
| Stock Repurch. | -$50 | -$50 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$5 | -$0 | $1 |
| Financing Cash Flow | -$257 | -$58 | -$3 | -$2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$153 | $17 | $7 | $31 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $300 | $284 | $277 | $246 |
| End Cash | $148 | $300 | $284 | $277 |
| Free Cash Flow | $57 | $9 | $27 | $31 |